Skip to content

The Effect of Cerebral Oxygenation on Postoperative Recovery in Intracranial Surgery

The Effect of Cerebral Oxygenation on Postoperative Recovery in Intracranial Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03714347
Acronym
Oxygenation
Enrollment
100
Registered
2018-10-22
Start date
2016-12-28
Completion date
2019-01-31
Last updated
2018-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Neoplasm

Keywords

cerebral oxygen monitoring, intracranial surgery, general anesthesia

Brief summary

The aim of this study was to investigate the effect of cerebral oxygenation on postoperative compilation in intracranial surgery.

Detailed description

Patients undergoing intracranial surgery will be divided into two groups; group (Group Control n = 100) and cerebral oxygenation monitoring group (Group Oxygen). all hemodynamic parameters such as systolic blood pressure and diastolic blood pressure, oxygen saturation, Et CO2, SpO2;% and BIS during anesthesia during anesthesia will be recorded intraoperatively and 10 postoperatively in 5 min intervals. After extubation, Modified Aldrete Score, GKS (Glasgow Coma Scale), Ramsey Sedation Scale (RSS), nausea-vomiting and pain will be recorded in the recovery room. Pain assessment will be done with Visual Analog Scale (VAS). Patient satisfaction will be recorded. MMST (mini mental state test) and ASEM (antisaccadic eye movement test) tests will be performed preoperatively and postoperatively at 1st, 2nd and 3rd days.

Interventions

DEVICEcerebral oxygen monitoring

probes will be placed on eyebrows on forehead

We will use routine monitoring intervention such as hate rate, arterial pressure, BIS. cerebral oxygen monitoring will not be applied to this group

Sponsors

Trakya University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
25 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Intracranial surgery will be performed * Age 25-75 * ASA in the I-II-III risk group

Exclusion criteria

* Under GKS 15 * heart failure, * renal insufficiency, * liver failure, * congenital neurological deficits

Design outcomes

Primary

MeasureTime frameDescription
cerebral oxygen monitoring datacerebral oxygen values reported will be measured at 10 min intervals (intraoperative) and It would be reported by the first postoperative 10 minute intervals up to 30 minutescerebral oxygen monitoring will measure peroperative

Countries

Turkey (Türkiye)

Contacts

Primary ContactSevtap Hekimoglu Sahin, Professor
sevtaphekimoglu@mynet.com
Backup ContactBeyhan Karamanlıoglu, professor
beykar@mynet.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026